JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 275K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowe, M. A.
Right arrow Articles by Fallon, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowe, M. A.
Right arrow Articles by Fallon, J. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2000/2/801/ $5.00
The Journal of Cell Biology, Volume 148, Number 4, February 21, 2000 801-810


Original Article

The Small Leucine-rich Repeat Proteoglycan Biglycan Binds to {alpha}-Dystroglycan and Is Upregulated in Dystrophic Muscle

Mark A. Bowea, Duane B. Mendisa, and Justin R. Fallona
a Department of Neuroscience, Brown University, Providence, Rhode Island 02912

Correspondence to: Justin R. Fallon, Department of Neuroscience, Brown University, Box 1953, 190 Thayer Street Providence, RI 02912. Tel:(401) 863-9308 Fax:(401) 863-1074 E-mail:justin_fallon{at}brown.edu.

The dystrophin-associated protein complex (DAPC) is necessary for maintaining the integrity of the muscle cell plasma membrane and may also play a role in coordinating signaling events at the cell surface. The {alpha}-/ß-dystroglycan subcomplex of the DAPC forms a critical link between the cytoskeleton and the extracellular matrix. A ligand blot overlay assay was used to search for novel dystroglycan binding partners in postsynaptic membranes from Torpedo electric organ. An ~125-kD dystroglycan-binding polypeptide was purified and shown by peptide microsequencing to be the Torpedo ortholog of the small leucine-rich repeat chondroitin sulfate proteoglycan biglycan. Biglycan binding to {alpha}-dystroglycan was confirmed by coimmunoprecipitation with both native and recombinant {alpha}-dystroglycan. The biglycan binding site was mapped to the COOH-terminal third of {alpha}-dystroglycan. Glycosylation of {alpha}-dystroglycan is not necessary for this interaction, but binding is dependent upon the chondroitin sulfate side chains of biglycan. In muscle, biglycan is detected at both synaptic and nonsynaptic regions. Finally, biglycan expression is elevated in muscle from the dystrophic mdx mouse. These findings reveal a novel binding partner for {alpha}-dystroglycan and demonstrate a novel avenue for interaction of the DAPC and the extracellular matrix. These results also raise the possibility of a role for biglycan in the pathogenesis, and perhaps the treatment, of muscular dystrophy.

Key Words: muscular dystrophy, dystrophin-associated protein complex, chondroitin sulfate proteoglycan, agrin, neuromuscular junction


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents